The regulatory effect of calcitonin gene-related peptide on bone metabolism of osteoblast cells co-cultured with breast cancer cells

Tumor

Volumn 29, Issue 9, 2009, Pages 833-837

  Yang, Chen ^a   Wang, Zhi Yu ^a   Zhao, Hui ^a   Yao, Yang ^a   Chen, Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Breast neoplasms; Calcitonin gene related peptide; Cell culture techniques; Osteoblasts

Indexed keywords

ALKALINE PHOSPHATASE; BETA ACTIN; CALCITONIN GENE RELATED PEPTIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE MATURATION; BONE METABOLISM; BONE MINERALIZATION; BREAST CANCER; CANCER CELL; CELL MATURATION; COCULTURE; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOBLAST; PROTEIN EXPRESSION; UPREGULATION;

EID: 77953400512     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2009.09.004     Document Type: Article

References (13)

1. FULLER K, WONG B, FOX S, et al. Trance is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts[J]. J Exp Med, 1998,188(5):997-1001.
2. KONG Y Y, YOSHIDA H, SAROSI I, et al, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis[J]. Nature, 1999,397(6717):315-323.
3. BUCAY N, SAROSI I, DUNSTAN C, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification[J]. Genes Dev, 1998,12(9):1260-1268.
4. BOYCE B F, XING L. Functions of RANKL/RANK/OPG in bone modeling and remodeling[J]. Arch Biochem Biophys, 2008,473(2):139-146.
5. KOSEI A, KANJI M, FRANÇOISE R, et al. RANKL/RANK/OPG: key therapeutic target in bone oncology[J]. Curr Drug Discov Technol, 2008,5(3):263-268.
6. KOSTENUIK P, NGUYEN H, MCCABE J, et al, Denosumab, a fully human monoclonal antibody to Rankl, inhibits bone resorption and increases bone density in knock-in mice that express chimeric (murine/human) Rankl[J]. J Bone Miner Res, 2008,24(2):182-195.
7. KAWASE T, OKUDA K, BURNS D. Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that respond differently to [Cys(Acm) (2,7)] calcitonin gene-related peptide and CGRP(8-37) [J]. Am J Physiol Cell Physiol, 2005,289(4):811-818.
8. BURNS D, STEHNO-BITTEL L, KAWASE T. Calcitonin gene-related peptide elevates calcium and polarizes membrane potential in MG-63 cells by both cAMP-independent and -dependent mechanisms[J]. Am J Physiol Cell Physiol, 2004,287(2):457-467.
9. THOMAS R, GUISE T, YIN J J, et al. Breast cancer cells interact with osteoblasts to support osteoclast formation[J]. Endocrinology, 1999,140(10):4451-4458.
10. KOMORI T. Regulation of bone development and maintenance by Runx2[J]. Front Biosci, 2008,13:898-903.
11. LIU W, TOYOSAWA S, FURUICHI T, et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures[J]. J Cell Biol, 2001,155(1):157-166.
12. BARNES G, JAVED A, WALLER S, et al. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells[J]. Cancer Res, 2003,63(10):2631-2637.